Skip to main content
Year archive

Pharming Group N.V. — 2021 filings

All 48 regulatory filings released by Pharming Group N.V. (PHARM) in 2021, sourced directly from the official regulator.

48 Filings
2021 Period
2021 filings (48)
Filing Released Lang
Pharming Group and Sanofi renew strategic manufacturing partnership agreement
Regulatory Filings
2021-12-23 English
Pharming Group reports financial results for the first nine months of 2021
Earnings Release 9M 2021
2021-10-28 English
6-K Filing
Foreign Filer Report
2021-10-28 English
S-8 Filing
Registration Form
2021-10-28 English
6-K
Foreign Filer Report
2021-10-22 English
Pharming Group Notice of 9M Results
Report Publication Announcement
2021-10-22 English
6-K
Foreign Filer Report
2021-09-14 English
Pharming announces results from clinical trials for the treatment of COVID-19 with RUCONEST®
Earnings Release H1 2021
2021-09-14 English
6-K/A
Foreign Filer Report
2021-08-09 English
6-K
Foreign Filer Report
2021-08-05 English
Pharming Group reports financial results for the first half of 2021
Earnings Release H1 2021
2021-08-05 English
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-08-04 English
6-K
Foreign Filer Report
2021-07-20 English
Pharming signs agreement with NewBridge Pharmaceuticals for the commercialization of RUCONEST® in the Middle East and North Africa
Regulatory Filings
2021-07-20 English
6-K
Foreign Filer Report
2021-07-01 English
Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo HSC Gene Therapy for Hereditary Angioedema
M&A Activity
2021-07-01 English
6-K
Foreign Filer Report
2021-06-24 English
Pharming announces completion of enrolment in Phase II/III study with leniolisib for activated PI3K delta syndrome
Regulatory Filings
2021-06-23 English
6-K Filing
Foreign Filer Report
2021-06-21 English
Pharming appoints Anurag Relan as Chief Medical Officer and Robert Friesen as Chief Scientific Officer
Board/Management Information
2021-06-18 English
Pharming Group N.V. announces the reimbursement of RUCONEST® in Spain
Regulatory Filings
2021-06-04 English
6-K Filing
Foreign Filer Report
2021-06-04 English
6-K
Foreign Filer Report
2021-06-01 English
Pharming Group to present at Jefferies Virtual Healthcare Conference
Investor Presentation
2021-06-01 English
Pharming Reports on Annual General Meeting of Shareholders
AGM Information
2021-05-20 English
6-K
Foreign Filer Report
2021-05-19 English
6-K
Foreign Filer Report
2021-05-17 English
Pharming celebrates the 10th annual "hae day :-)"
Regulatory Filings
2021-05-17 English
Pharming Group reports financial results for the first quarter of 2021
Earnings Release Q1 2021
2021-05-14 English
6-K
Foreign Filer Report
2021-05-13 English
6-K
Foreign Filer Report
2021-04-22 English
Pharming announces enrolment of first patient in multicentre Phase IIb clinical trial of RUCONEST® for the prevention of acute kidney injury after myocardial infarction
Regulatory Filings
2021-04-22 English
Pharming Group announces the filing of its 2020 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
Report Publication Announcement
2021-04-08 English
6-K
Foreign Filer Report
2021-04-07 English
Pharming Group announces the publication of its 2020 Annual Report and convenes its 2021 AGM
Report Publication Announcement
2021-04-07 English
20-F Filing
Annual Report FY 2020
2021-04-07 English
6-K Filing
Foreign Filer Report
2021-04-07 English
Annual Report 2020
Annual Report FY 2020
2021-04-06 English
Pharming Group announces the intention to nominate three Non-Executive Directors to the Board of Directors
Board/Management Information
2021-03-23 English
6-K Filing
Foreign Filer Report
2021-03-23 English
Pharming Group to present at 31st Annual Oppenheimer Healthcare Conference
Regulatory Filings
2021-03-16 English
6-K
Foreign Filer Report
2021-03-16 English
6-K
Foreign Filer Report
2021-03-11 English
Pharming Group to Present at BioCapital Europe 2021
Regulatory Filings
2021-03-11 English
6-K
Foreign Filer Report
2021-03-04 English
Pharming Group reports financial results for full year 2020
Regulatory Filings
2021-03-04 English
Pharming Group, in collaboration with Invitae Corporation, launches genetic testing program ‘navigateAPDS’ in US and Canada
Regulatory Filings
2021-03-02 English
6-K Filing
Foreign Filer Report
2021-03-02 English